✦ LIBER ✦

Phase II study of Xyotax (CT-2103) in patients with colorectal cancer having recurrent disease after treatment with a 5-fluorouracil-containing regimen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

275 Phase 2 study of CT-2103 in patients

✍ C. Redfern; J. Schulz; H. Burriss; M.G. Bolton 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Phase I/II study of CT-2103 (Xyotax) in

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 159 KB

A Multicenter Phase II Study of Irinotec

✍ Miguel Méndez; Antonieta Salut; Carlos García-Girón; Marta Navalon; Pilar Diz; M 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 106 KB

Phase I/II study of irinotecan, 5-fluoro

✍ Ayumu Goto; Yasuhide Yamada; Ayumu Hosokawa; Takashi Ura; Tatsuhiro Arai; Tetsuy 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

A Phase II Study of ANGIOZYME® in combin

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 137 KB

A Phase II Study of Oxaliplatin, 5-Fluor

✍ Sam J. Lubner; Noelle K. LoConte; Kyle D. Holen; William Schelman; James P. Thom 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 117 KB